openPR Logo
Press release

Interventional Cardiology Devices Market Size, Trends, Growth, Opportunities 2024-2032 | Medtronic, Edward Lifesciences, and Abbott

10-10-2024 09:03 AM CET | Health & Medicine

Press release from: Fortune Business Insights

Interventional Cardiology Devices Market

Interventional Cardiology Devices Market

The global interventional cardiology devices market size was valued at USD 15.61 billion in 2023. The market is projected to grow from USD 16.69 billion in 2024 to USD 29.32 billion by 2032, exhibiting a CAGR of 7.3% during the forecast period (2024-2032).

The interventional cardiology devices market is experiencing steady growth, driven by advancements in minimally invasive procedures for treating heart conditions. This press release explores the key industry developments, leading segment, and future outlook for this vital medical technology sector.

๐——๐—ถ๐˜€๐—ฐ๐—ผ๐˜ƒ๐—ฒ๐—ฟ ๐—ช๐—ต๐—ฎ๐˜ ๐—ฌ๐—ผ๐˜‚'๐—ฟ๐—ฒ ๐— ๐—ถ๐˜€๐˜€๐—ถ๐—ป๐—ด: ๐—š๐—ฒ๐˜ ๐—ฎ ๐—™๐—ฟ๐—ฒ๐—ฒ ๐—ฅ๐—ฒ๐—ฝ๐—ผ๐—ฟ๐˜ (๐—ฃ๐——๐—™) ๐—ฆ๐—ฎ๐—บ๐—ฝ๐—น๐—ฒ: https://www.fortunebusinessinsights.com/enquiry/sample/interventional-cardiology-devices-market-107414

๐— ๐—ฎ๐—ฟ๐—ธ๐—ฒ๐˜ ๐—ผ๐—ป ๐˜๐—ต๐—ฒ ๐—ฅ๐—ถ๐˜€๐—ฒ ๐˜„๐—ถ๐˜๐—ต ๐—ฆ๐˜๐—ฟ๐—ฎ๐˜๐—ฒ๐—ด๐—ถ๐—ฐ ๐—”๐—ฐ๐—พ๐˜‚๐—ถ๐˜€๐—ถ๐˜๐—ถ๐—ผ๐—ป๐˜€:

โ€ข A recent key development in the market is the acquisition of a major share in Acotec Scientific Holdings by Boston Scientific Corporation in December 2022. This move highlights the growing importance of strategic acquisitions for expanding product portfolios and market reach, particularly in emerging regions like China.

๐—ง๐—ผ๐—ฝ ๐—ฃ๐—น๐—ฎ๐˜†๐—ฒ๐—ฟ๐˜€ ๐—ถ๐—ป ๐—œ๐—ป๐˜๐—ฒ๐—ฟ๐˜ƒ๐—ฒ๐—ป๐˜๐—ถ๐—ผ๐—ป๐—ฎ๐—น ๐—–๐—ฎ๐—ฟ๐—ฑ๐—ถ๐—ผ๐—น๐—ผ๐—ด๐˜† ๐——๐—ฒ๐˜ƒ๐—ถ๐—ฐ๐—ฒ๐˜€:

โ€ข Edward Lifesciences (U.S.)
โ€ข Boston Scientific Corporation (U.S.)
โ€ข Abbott (U.S.)
โ€ข Medtronic (Ireland)
โ€ข BIOTRONIK SE & Co. KG (Germany)
โ€ข iVascular (Spain)
โ€ข Terumo Corporation (Japan)
โ€ข Teleflex Incorporated (U.S.)
โ€ข B. Braun SE (Germany)
โ€ข Alvimedica (Turkey)

๐— ๐—ฎ๐—ฟ๐—ธ๐—ฒ๐˜ ๐——๐—ฟ๐—ถ๐˜ƒ๐—ฒ๐—ฟ๐˜€ ๐—ฎ๐—ป๐—ฑ ๐—ฅ๐—ฒ๐˜€๐˜๐—ฟ๐—ฎ๐—ถ๐—ป๐˜๐˜€:

๐‘บ๐’†๐’—๐’†๐’“๐’‚๐’ ๐’‡๐’‚๐’„๐’•๐’๐’“๐’” ๐’‚๐’“๐’† ๐’‘๐’“๐’๐’‘๐’†๐’๐’๐’Š๐’๐’ˆ ๐’•๐’‰๐’† ๐’Š๐’๐’•๐’†๐’“๐’—๐’†๐’๐’•๐’Š๐’๐’๐’‚๐’ ๐’„๐’‚๐’“๐’…๐’Š๐’๐’๐’๐’ˆ๐’š ๐’…๐’†๐’—๐’Š๐’„๐’†๐’” ๐’Ž๐’‚๐’“๐’Œ๐’†๐’• ๐’‡๐’๐’“๐’˜๐’‚๐’“๐’…:

โ€ข ๐—ฅ๐—ถ๐˜€๐—ถ๐—ป๐—ด ๐—ฃ๐—ฟ๐—ฒ๐˜ƒ๐—ฎ๐—น๐—ฒ๐—ป๐—ฐ๐—ฒ ๐—ผ๐—ณ ๐—–๐—ฎ๐—ฟ๐—ฑ๐—ถ๐—ผ๐˜ƒ๐—ฎ๐˜€๐—ฐ๐˜‚๐—น๐—ฎ๐—ฟ ๐——๐—ถ๐˜€๐—ฒ๐—ฎ๐˜€๐—ฒ๐˜€: The increasing incidence of heart disease, a leading cause of mortality globally, is driving demand for minimally invasive treatment options.
โ€ข ๐—”๐—ฑ๐˜ƒ๐—ฎ๐—ป๐—ฐ๐—ฒ๐—บ๐—ฒ๐—ป๐˜๐˜€ ๐—ถ๐—ป ๐—ง๐—ฒ๐—ฐ๐—ต๐—ป๐—ผ๐—น๐—ผ๐—ด๐˜†:Continuous advancements in interventional cardiology devices like stents, balloons, and catheters are leading to more effective and minimally invasive procedures.
โ€ข ๐—š๐—ฟ๐—ผ๐˜„๐—ถ๐—ป๐—ด ๐—š๐—ฒ๐—ฟ๐—ถ๐—ฎ๐˜๐—ฟ๐—ถ๐—ฐ ๐—ฃ๐—ผ๐—ฝ๐˜‚๐—น๐—ฎ๐˜๐—ถ๐—ผ๐—ป: An ageing population with a higher risk of heart disease is creating a larger market for these devices.

๐™ƒ๐™ค๐™ฌ๐™š๐™ซ๐™š๐™ง, ๐™˜๐™š๐™ง๐™ฉ๐™–๐™ž๐™ฃ ๐™˜๐™๐™–๐™ก๐™ก๐™š๐™ฃ๐™œ๐™š๐™จ ๐™ง๐™š๐™ข๐™–๐™ž๐™ฃ:

โ€ข ๐—›๐—ถ๐—ด๐—ต ๐—–๐—ผ๐˜€๐˜ ๐—ผ๐—ณ ๐—ฃ๐—ฟ๐—ผ๐—ฐ๐—ฒ๐—ฑ๐˜‚๐—ฟ๐—ฒ๐˜€: The cost of interventional cardiology procedures can be a barrier for some patients, especially without adequate insurance coverage.
โ€ข ๐—ฅ๐—ฒ๐—ถ๐—บ๐—ฏ๐˜‚๐—ฟ๐˜€๐—ฒ๐—บ๐—ฒ๐—ป๐˜ ๐—–๐—ต๐—ฎ๐—น๐—น๐—ฒ๐—ป๐—ด๐—ฒ๐˜€: Fluctuating reimbursement policies for these procedures can affect hospital and physician adoption of new technologies.

๐—™๐—ผ๐—ฟ ๐—™๐˜‚๐—น๐—น ๐—ฅ๐—ฒ๐—ฝ๐—ผ๐—ฟ๐˜ ๐—–๐—ผ๐˜ƒ๐—ฒ๐—ฟ๐—ฎ๐—ด๐—ฒ ๐—ฉ๐—ถ๐˜€๐—ถ๐˜: https://www.fortunebusinessinsights.com/interventional-cardiology-devices-market-107414

๐— ๐—ฎ๐—ฟ๐—ธ๐—ฒ๐˜ ๐—ฅ๐—ฒ๐—ฝ๐—ผ๐—ฟ๐˜ ๐—–๐—ผ๐˜ƒ๐—ฒ๐—ฟ๐—ฎ๐—ด๐—ฒ:

๐™๐™ค๐™ง ๐™– ๐™˜๐™ค๐™ข๐™ฅ๐™ง๐™š๐™๐™š๐™ฃ๐™จ๐™ž๐™ซ๐™š ๐™ช๐™ฃ๐™™๐™š๐™ง๐™จ๐™ฉ๐™–๐™ฃ๐™™๐™ž๐™ฃ๐™œ ๐™ค๐™› ๐™ฉ๐™๐™š ๐™ž๐™ฃ๐™ฉ๐™š๐™ง๐™ซ๐™š๐™ฃ๐™ฉ๐™ž๐™ค๐™ฃ๐™–๐™ก ๐™˜๐™–๐™ง๐™™๐™ž๐™ค๐™ก๐™ค๐™œ๐™ฎ ๐™™๐™š๐™ซ๐™ž๐™˜๐™š๐™จ ๐™ข๐™–๐™ง๐™ ๐™š๐™ฉ, ๐™๐™ค๐™ง๐™ฉ๐™ช๐™ฃ๐™š ๐˜ฝ๐™ช๐™จ๐™ž๐™ฃ๐™š๐™จ๐™จ ๐™„๐™ฃ๐™จ๐™ž๐™œ๐™๐™ฉ๐™จ' ๐™ง๐™š๐™ฅ๐™ค๐™ง๐™ฉ ๐™ค๐™›๐™›๐™š๐™ง๐™จ ๐™ž๐™ฃ-๐™™๐™š๐™ฅ๐™ฉ๐™ ๐™–๐™ฃ๐™–๐™ก๐™ฎ๐™จ๐™ž๐™จ ๐™ค๐™ฃ:

โ€ข ๐— ๐—ฎ๐—ฟ๐—ธ๐—ฒ๐˜ ๐—š๐—ฟ๐—ผ๐˜„๐˜๐—ต ๐—ฃ๐—ฟ๐—ผ๐—ท๐—ฒ๐—ฐ๐˜๐—ถ๐—ผ๐—ป๐˜€: The report provides detailed market size and growth forecasts for the interventional cardiology devices market over the forecast period.
โ€ข ๐— ๐—ฎ๐—ฟ๐—ธ๐—ฒ๐˜ ๐—ฆ๐—ฒ๐—ด๐—บ๐—ฒ๐—ป๐˜๐—ฎ๐˜๐—ถ๐—ผ๐—ป: The report segments the market based on product type (coronary stents, balloons & catheters, heart valves, embolic protection devices), application (coronary artery disease, peripheral artery disease, valvular heart disease), and end-user (hospitals, clinics, ambulatory surgical centres).
โ€ข ๐—–๐—ผ๐—บ๐—ฝ๐—ฒ๐˜๐—ถ๐˜๐—ถ๐˜ƒ๐—ฒ ๐—Ÿ๐—ฎ๐—ป๐—ฑ๐˜€๐—ฐ๐—ฎ๐—ฝ๐—ฒ: The report identifies key players in the market and analyzes their competitive strategies.
โ€ข ๐—ฅ๐—ฒ๐—ด๐—ถ๐—ผ๐—ป๐—ฎ๐—น ๐—œ๐—ป๐˜€๐—ถ๐—ด๐—ต๐˜๐˜€: The report provides insights into the growth potential of interventional cardiology devices in different geographical regions.

๐—ฆ๐—ฒ๐—ด๐—บ๐—ฒ๐—ป๐˜๐—ฎ๐˜๐—ถ๐—ผ๐—ป ๐—”๐—ป๐—ฎ๐—น๐˜†๐˜€๐—ถ๐˜€:

๐—–๐—ผ๐—ฟ๐—ผ๐—ป๐—ฎ๐—ฟ๐˜† ๐—ฆ๐˜๐—ฒ๐—ป๐˜๐˜€ ๐—Ÿ๐—ฒ๐—ฎ๐—ฑ ๐˜๐—ต๐—ฒ ๐— ๐—ฎ๐—ฟ๐—ธ๐—ฒ๐˜:

The coronary stents segment will dominate the interventional cardiology devices market during the forecast period. This is due to the high prevalence of coronary artery disease and the widespread use of stents to open blocked arteries.

๐—” ๐—–๐—ผ๐—บ๐—ฝ๐—ฒ๐˜๐—ถ๐˜๐—ถ๐˜ƒ๐—ฒ ๐—Ÿ๐—ฎ๐—ป๐—ฑ๐˜€๐—ฐ๐—ฎ๐—ฝ๐—ฒ:

The market exhibits a dynamic and competitive landscape. Established medical device companies are constantly innovating and expanding their product portfolios. Additionally, smaller players are emerging with specialized interventional cardiology devices.

๐—ง๐—ต๐—ฒ ๐—™๐˜‚๐˜๐˜‚๐—ฟ๐—ฒ ๐—ผ๐—ณ ๐—œ๐—ป๐˜๐—ฒ๐—ฟ๐˜ƒ๐—ฒ๐—ป๐˜๐—ถ๐—ผ๐—ป๐—ฎ๐—น ๐—–๐—ฎ๐—ฟ๐—ฑ๐—ถ๐—ผ๐—น๐—ผ๐—ด๐˜† ๐——๐—ฒ๐˜ƒ๐—ถ๐—ฐ๐—ฒ๐˜€:

The interventional cardiology devices market is poised for continued growth as technological advancements lead to more efficient, cost-effective, and patient-friendly solutions for treating heart conditions. With a growing focus on minimally invasive procedures and a rising burden of cardiovascular diseases, the demand for interventional cardiology devices is expected to remain strong in the years to come.

๐—–๐˜‚๐˜€๐˜๐—ผ๐—บ๐—ถ๐˜‡๐—ฒ ๐—ง๐—ต๐—ถ๐˜€ ๐—ฅ๐—ฒ๐—ฝ๐—ผ๐—ฟ๐˜ ๐—”๐—ฐ๐—ฐ๐—ผ๐—ฟ๐—ฑ๐—ถ๐—ป๐—ด ๐—ง๐—ผ ๐—ฌ๐—ผ๐˜‚๐—ฟ ๐—–๐—ผ๐—ป๐˜ƒ๐—ฒ๐—ป๐—ถ๐—ฒ๐—ป๐—ฐ๐—ฒ: https://www.fortunebusinessinsights.com/enquiry/ask-for-customization/interventional-cardiology-devices-market-107414

Contact Us:
Fortune Business Insightsโ„ข Pvt. Ltd.
9th Floor, Icon Tower,
Baner, Pune-411045,
Maharashtra, India.
Phone:
U.S.: +1 833 909 2966 (Toll-Free)
UK +44 808 502 0280 (Toll-Free)
APAC +91 744 740 1245
Email: sales@fortunebusinessinsights.com

๐€๐›๐จ๐ฎ๐ญ ๐”๐ฌ:
Fortune Business Insightsโ„ข offers expert corporate analysis and accurate data, helping organizations make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Interventional Cardiology Devices Market Size, Trends, Growth, Opportunities 2024-2032 | Medtronic, Edward Lifesciences, and Abbott here

News-ID: 3686047 • Views: โ€ฆ

More Releases from Fortune Business Insights

Future of Renewable Energy Market Insights: Growth Drivers, and Regional Developments
Future of Renewable Energy Market Insights: Growth Drivers, and Regional Develop โ€ฆ
Global Renewable Energy Market Overview The global renewable energy market size was valued at USD 954 billion in 2023. The market is projected to grow from USD 1,020.94 billion in 2024 to USD 1,574.17 billion by 2032, exhibiting a CAGR of 5.56% during the forecast period. Asia Pacific dominated the renewable energy market with a market share of 67.76% in 2023. The Renewable energy market in the U.S. is projected toโ€ฆ
DC Drives Market Overview: Opportunities, Growth Drivers, and Key Applications
DC Drives Market Overview: Opportunities, Growth Drivers, and Key Applications
Market Overview The global DC drives market size was valued at USD 4.34 billion in 2018 and is projected to reach USD 9.23 billion by 2032, exhibiting a CAGR of 5.59% during the forecast period of 2019-2032. Asia Pacific dominated the global market with a share of 28.8% in 2018. The DC drives market in the U.S. is projected to grow significantly, reaching an estimated value of USD 1.59 billion byโ€ฆ
Humanoid Robots Market: An In-depth B2B Analysis of Size, Share, and Future Growth
Humanoid Robots Market: An In-depth B2B Analysis of Size, Share, and Future Grow โ€ฆ
Brief Market Overview: The global humanoid robots market is rapidly transitioning from a nascent field into a major growth sector, with its value escalating from USD 2.43 billion in 2023 to a projected USD 66.0 billion by 2032, demonstrating a remarkable CAGR of 45.5%. These complex machines, which merge mechanical, electrical, and software engineering, are moving beyond research labs into real-world applications across industrial, service, and household sectors. This explosive growthโ€ฆ
Methanol Market Poised for Remarkable Growth, set to Reach USD 46.32 billion by 2032 with a CAGR of 4.5%.
Methanol Market Poised for Remarkable Growth, set to Reach USD 46.32 billion by โ€ฆ
The global methanol market size was valued at USD 31.26 billion in 2023. It is projected to grow from USD 32.70 billion in 2024 to USD 46.32 billion by 2032, exhibiting a CAGR of 4.5% during the forecast period. The global methanol market size is set to gain traction from the urgent need to lower environmental pollution caused by the surging usage of heavy fuels, such as diesel and gasoline. Pollutionโ€ฆ

All 5 Releases


More Releases for Interventional

Argon Medical's SuperCore Advantage In Interventional Oncology: The Driving Engi โ€ฆ
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. What Is the Expected CAGR for the Interventional Oncology Devices Market Through 2025? The market for interventional oncology devices has seen a robust expansion in recent times. Its growth trajectory forecasts a swell from $2.39 billion in 2024 to $2.52 billion in 2025, reflecting a compound annual growth rateโ€ฆ
Neurovascular Devices/Interventional Neurology Market Poised for Growth Amid Adv โ€ฆ
The latest report "Neurovascular Devices/Interventional Neurology Market Share, Size, Growth, Opportunities, and Forecast 2024-2032" by Market Insights delivers a thorough analysis of the industry, encompassing market insights. It also covers competitor and regional analysis, along with recent advancements in the market. crucial factors boosting demand include a lesser focus on enhancing the seeker experience, managing large aspirant pools effectively, and using data analytics to optimize reclamation strategies. The report presentsโ€ฆ
Global Interventional Radiology Market Size & Trends
According to a new market research report published by Global Market Estimates, the global interventional radiology market is projected to grow at a CAGR of 5.4% from 2023 to 2028. The primary factors propelling the market growth are the increasing demand for minimally invasive procedures and the rising prevalence of chronic diseases such as heart disease, asthma, and others. Browse 147 Market Data Tables and 115 Figures spread through 163 Pages andโ€ฆ
Interventional X-Ray Contrast Systems Market - Leading the way in high-quality i โ€ฆ
Newark, New Castle, USA: The "Interventional X-Ray Contrast Systems Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors. Interventional X-Ray Contrast Systems Market: https://www.growthplusreports.com/report/interventional-xray-contrast-systems-market/8613 This latest report researches theโ€ฆ
Interventional Radiology Drainage Procedures Market - Advanced Interventional Ra โ€ฆ
Newark, New Castle, USA: The "Interventional Radiology Drainage Procedures Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors. Interventional Radiology Drainage Procedures Market: https://www.growthplusreports.com/report/interventional-radiology-drainage-procedures-market/8596 This latest report researches theโ€ฆ
Interventional Oncology Market By Top Players -
Global Interventional Oncology Market Analysis According to Verified Market Research, the Global Interventional Oncology Market was valued at USD 1.78 Billion in 2018 and is projected to grow at a CAGR of 6.83% to reach USD 2.96 Billion by 2026, over the forecast period. What is Interventional Oncology? Interventional oncology deals with the diagnosis and treatment of cancer using minimally invasive procedures that are performed under image guidance. Interventional oncology is used toโ€ฆ